Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
TGA issues warning over GLP-1-based drugs' potential to cause rare eye disorder Fri 24 Jul 2026 at 11:13am In short: The Therapeutic Goods Administration is warning of a rare but serious eye disorder that could be caused by GLP-1-based drugs
2 Comparison: A product with a clear daily amount is more actionable than a page that only says supports overall health and wellness. A wellness phrase is not a feeding plan
Specialized pharmacies create compounded versions rather than pharmaceutical manufacturing facilities
This litigation represents people alleging eye injuries from Mounjaro and other GLP-1 drugs
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
